US Patent 8580858 Compositions for the treatment of CNS-related conditions
Patent 8580858 was granted and assigned to Adamas Pharmaceuticals, Inc. on November, 2013 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8580858 Compositions for the treatment of CNS-related conditions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.